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Abstract A nuclear localization signal (NLS) is required for the 
transport of karyophilic proteins from the cytoplasm to the nu- 
cleus. In this study, NLS was examined in terms of its effect on 
diverse cellular functions such as protein phosphorylation reac- 
tions. When synthetic peptides containing the NLS of SV40 T- 
antigen were injected into the cytoplasm of Xenopus oocytes, and 
the oocytes incubated with [32p]phosphorus-containing medium, 
a 32 kDa protein was found to be preferentially phosphorylated 
in an NLS-dependent manner. The incubation of fractionated 
cytosolic extracts prepared from mouse Ehrlich ascites tumor 
cells with [3,-32p]ATP in the presence of the NLS peptides, results 
in the stimulation of the phosphorylation of several proteins. 
Similar in vitro stimulation was observed by other functional NLS 
peptides uch as those of polyoma virus T-antigen and nucleoplas- 
min. Little or no stimulation, however, was detected for peptides 
of mutant type and reverse type NLS of SV40 T-antigen, and the 
C-terminal portion of lamin B. Using an in vitro assay, the phos- 
phorylation activity was fractionated chromatographically and a 
fraction was obtained which contained a high level of activity. The 
fraction was found to contain three major proteins having molec- 
ular masses of 95, 70, and 43 kDa. The in vivo and in vitro results 
are consistent with the existence of a protein kinase, called NLS 
kinase, that is specifically activated by NLS peptides. 
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I. Introduction 
Mediated nuclear protein import is a two step process com- 
prising: (a) an ATP-independent binding to the cytoplasmic 
face of nuclear pores, and, (b) ATP-dependent translocation 
through nuclear pore complexes (NPCs) [1,2]. The selective 
nuclear transport of karyophilic proteins is directed by short 
amino acid sequences termed nuclear localization signals 
(NLSs) [3-8]. 
Recent reports [9-12] suggest hat several cytosolic factors 
are required for nuclear protein import. In higher eukaryotes, 
a 70 kDa heat-shock cognate protein (hsc70) represents one 
such cytoplasmic factor, which has been demonstrated in both 
living cells [13] and in vitro transport systems [14-16]. 
Using a semi-intact ell assay system, Imamoto et al. recently 
demonstrated that an SV40 T-antigen NLS-containing karyo- 
phile forms a stable complex (nuclear pore-targeting complex: 
*Corresponding author. Fax: (81) (6) 879 3219. 
PTAC) with cytoplasmic components to target nuclear pores 
[17]. They also reported that a 58 kDa component of PTAC 
(PTAC 58), the mouse homologue of Xenopus importin 60 
which is essential for the first step of nuclear protein import 
[18], has NLS-binding activity and that anti-PTAC 58 antibod- 
ies inhibited in vivo nuclear import [19]. The PTAC 58 was also 
found to be homologous to a number of proteins. Among these 
are the 54/56 kDa NLS-receptor from the cytosol of bovine 
erythrocytes, previously reported by Adam and Gerace [20], 
karyopherin ~ isolated from a Xenopus oocyte cytosolic 
subfraction by Radu et al. [21], and hSRPI obtained by Weis 
et al. [22]. A 97 kDa component of PTAC (PTAC 97) was 
required for the docking of import substrates to nuclear ims 
in conjunction with PTAC 58 [23], and was found to be the 
mouse homologue of karyopherin fl [24], importin 90 [25], and 
p97 [26]. 
Moore and Blobel, using an in vitro, semi-intact ell system, 
purified a 25 kDa protein as a translocation factor fi'om frac- 
tion B of Xenopus oocyte cytosol and showed it to be a small 
GTP binding protein, Ran/TC4 [27]. RCC1 acts as a guanine 
nucleotide exchange factor for Ran/TC4 and tsBN2 is a temper- 
ature-sensitive RCC1 mutant cell line derived from the BHK 
cell line. It has a point mutation in RCCI and arrests in G~ or 
induces premature chromosome condensation at non-permis- 
sive temperatures [28,29]. Tachibana et al. reported a decrease 
in the efficiency of nuclear protein transport for tsBN2 cells 
cultured at non-permissive t mperatures and the accumulation 
of a factor that suppresses nuclear import [30]. In this report, 
we present data which shows that the RCC1-Ran/TC4 system 
plays an important role in nuclear protein import in living 
mammalian cells. 
Nuclear protein import would be expected to occur as the 
result of a co-operative effect of these molecules. It is unclear, 
however, whether this co-operation is regulated by cellular con- 
ditions. For example, the efficiency of nuclear protein transport 
may change during the cell cycle or in response to the amount 
of nuclear proteins to be transported. It is well known that 
protein phosphorylation constitutes an important mechanism 
for the rapid and efficient regulation of cellular functions and 
the structural or functional changes of proteins related to, for 
example, signal transduction i the cell and the cell cycle. 
In this report, we examined the role of NLS in cellular pro- 
tein phosphorylation. Protein phosphorylation was stimulated 
by NLS peptides in vivo and in vitro. We also report the iden- 
tification and purification of a protein kinase which is activated 
by NLS peptides in higher eukaryotes, which we designate a 
nuclear localization signal-activated kinase (NLS kinase). 
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2. Materials and methods 
2.1. Synthetic peptides 
Synthetic peptides of SV40 T-antigen wild type NLS (CYGGPKK- 
KRKVEDP), its mutant ype NLS (CYGGPKTKRKVEDP), its re- 
verse type NLS (CYGGPDEVKRKKKP), nucleoplasmin NLS (AV- 
KRPAATKKGQAKKKKLDC), polyoma virus T-antigen NLS (C- 
DPPRTPVSRKRPRPAC), and the C-terminal portion of lamin B 
(AKEFHYPQQKSGNKNC) were purchased from the Peptide Insti- 
tute (Osaka, Japan). 
2.2. Microinjection into Xenopus ooo'tes and in vivo phosphorylation 
assay 
50 nl of 20 mM synthetic peptides containing SV40 T-antigen wild 
type NLS or its transport incompetent mutant ype NLS, dissolved in 
50 mM HEPES (pH 7.3), were microinjected into the cytoplasm of 
unfertilized Xenopus oocytes (stageV VI) in MBS (modified Barth 
solution: 88 mM NaC1, 1 mM KC1, 0.41 mM CaCI2, 0.82 mM MgSO4, 
2.4 mM NaHCO3, and 20 mM HEPES (pH 7.3)) using a micromanip- 
ulator (Narishige 1M6, MN-153). As a control, 50 nl of 50 mM HEPES 
(pH 7.3) was microinjected. Immediately after microinjection, the 
oocytes were labeled by treatment with 0.5 mCi/ml of [32p]phosphorus 
in MBS for 30 min. These procedures were performed at 21°C. Oocytes 
were homogenized in two volumes of homogenization buffer (20 mM 
sodium pyrophosphate, 10 mM ethylene glycol-bis-N,N,N',N'-t 
etraacetic acid (EGTA), 10 mM MgCI2, 100 mM NaF, 1 mM Na3VO 4, 
1 mM dithiothreitol (DTT), 10/~g/ml leupeptin, 1¢tg/ml aprotinin, 0.1 
mM phenylmethylsulfonyl fluoride (PMSF), and 20 mM Tris-HCl (pH 
7.5)) and extracts were obtained by centrifugation i itially at 5,000 x g 
for 5 rain and finally at 300,000 x g for 30 min (model TLA100.2; 
Beckman Instruments) [31]. The resulting extracts were applied to 1/3 
volume of DEAE-Sephacel equilibrated with homogenization buffer at 
4°C [32] and eluted stepwise with a homogenization buffer containing 
0.23 M, 1 M, and 2 M NaCl using a batch method. Each fraction was 
subjected to SDS-PAGE followed by autoradiography. 
2.3. Kinase purification 
Ehrlich ascites tumor cells, freshly harvested from the abdominal 
cavity of mice, were washed with cold 10 mM phosphate buffer (pH 7.4) 
containing 138 mM NaC1 and 2.7 mM KCI and lysed in hypotonic 
buffer A (20 mM HEPES (pH 7.2), 10 mM KC1, 5 mM MgCI2, 0.2 mM 
PMSF, 10/tg/ml leupeptin, and 2/lg/ml cytochalasin B) by 10 strokes 
of a homogenizer. The lysate was clarified by centrifugation at 
200,000 x g for 90 min (model 50.2Ti; Beckman Instruments) and ap- 
plied to DEAE-Sephacel equilibrated with buffer B (the same as buffer 
A but 30 mM in KC1). Materials were eluted stepwise with buffer B 
containing 130 mM, 230 mM, 530 mM, and 1 M KCI. The 530 mM 
KCI fraction was then applied to hydroxylapatite g l (HTP: Bio-Rad 
Laboratories) equilibrated with buffer B. This column was washed with 
buffer C [30 mM potassium phosphate (pH 7.2), 300 mM KC1, 5 mM 
MgCI2, 0.2 mM PMSF, 10/~g/ml leupeptin], and the bound materials 
were then eluted with buffer C containing 75 mM, 125 mM, and 250 
mM potassium phosphate, respectively. The 125 mM potassium phos- 
phate fraction was applied to Sephacryl S-300 (Pharmacia Biotechnol- 
ogy Inc.) equilibrated with buffer B. Kinase fractions and fractions 
containing, prominently, a phosphorylated 34kDa protein (p34) were 
separated on this column. The kinase fractions eluted as two peaks. 
Fractions containing p34 were collected as a substrate fraction. The 
first peak, which contained kinase with a higher activity, was applied 
to Mono-Q HR 5/5 column (Pharmacia Biotechnology Inc.) equili- 
brated with buffer D (20 mM Tris-HC1 (pH 7.2), 5 mM MgC12, 300 mM 
KC1, 0.2 mM PMSF, 10/lg/ml leupeptin) and eluted using a linear 
gradient of 0.3-2 M KC1 in buffer D by HPLC ( Pharmacia LKB 
Biotechnology Inc.). 
2.4. In vitro phosphorylation assay 
In vitro phosphorylation reactions were performed with or without 
0.5 1.0 mM peptides in the presence of 10/~M ATP containing 1,uCi 
of [y-32p]ATP in an assay buffer (50 mM Tris-HCl (pH 7.5), 30 mM 
KC1, 5 mM MgCI2) at 30°C for 10 min. The reaction was terminated 
by the addition of Laemmli's ample buffer and then heating to boiling. 
After SDS-PAGE, bands were detected by autoradiography. Histone 
H1, protamine, myelin basic protein, caseine, and phosvitin (Sigma 
Chem.) were used as kinase substrates ata concentration f0.5 mg/ml. 
Crude nuclear pore complex proteins, isolated from rat liver [33], were 
also examined as substrates at a concentration of 0.5 mg/ml using the 
same assay condition. Apparent protein aggregation was not observed 
under these conditions. 
3. Results and discussion 
Initial experiments were directed at determining if N LS itself 
affects intracellular protein phosphorylat ion i vivo. Immedi- 
ately after the injection of 50 nl of a 20 mM peptide solution 
of SV40 T-antigen wild type NLS, its mutant  type NLS, or 
buffer alone were injected into the cytoplasm of Xenopus 
oocytes, and the oocytes were then incubated in a medium 
containing [32p]phoshorus for 30 min. The resulting extracts 
were first applied to DEAE-Sephacel  and fractionated by step- 
wise elution with 0.23 M, 1 M, and 2 M NaC1. Each fraction 
was separated by SDS-PAGE followed by autoradiography. As
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Fig. 1. Protein phosphorylation pattern in Xenopus oocytes injected 
with wild type NLS peptides of SV40 T-antigen. 50 nl of 20 mM 
synthetic peptides containing SV40 T-antigen wild type NLS (lanes 2, 
5, and 8) or its mutant ype NLS (lanes 3, 6, and 9) dissolved in 50 mM 
HEPES (pH 7.3) were microinjected into the cytoplasm of Xenopus 
oocytes (stage V-VI) in MBS by a micromanipulator. As a control, 50 
nl of 50 mM HEPES (pH 7.3) (lanes 1, 4, and 7) was microinjected. 
Immediately after the microinjection, oocytes were labeled with 0.5 
mCi/ml of [32p]phosphorus in MBS for 30 min at 21 °C. Labeled oocytes 
were homogenized in two volumes of 20 mM sodium pyrophosphate, 
10 mM EGTA, 10 mM MgCI 2, 100 mM NaF, 1 mM Na3VO4, 1 mM 
DTT, 10 ,ug/ml leupeptin, 1gtg/ml aprotinin, 0.1 mM PMSF, and 20 
mM Tris-HC1 (pH 7.5) and the extracts were obtained by centrifugation 
first at 5,000 × g for 5 min and then at 300,000 × g for 30 min. These 
extracts were applied to 1/3 volume of DEAE-Sephacel at 4°C and 
eluted with buffer containing 0.23 M (lanes 1 3), 1 M (lanes 4-6), and 
2 M (lanes 7 9) NaC1 by batch method. Each fraction was subjected 
to SDS-PAGE followed by autoradiography. The arrow indicates the 
position of p32. 
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Fig. 2. In vitro phosphorylation with wild type NLS peptides of SV40 
T-antigen. Ehrlich ascites tumor cells, freshly harvested from abdomi- 
nal cavity of mice, were washed with 10 mM phosphate buffered saline 
and lysed in hypotonic buffer A (20 mM HEPES (pH 7.2), 10 mM KC1, 
5 mM MgC12, 0.2 mM PMSF, 10¢tg/ml leupeptin, and 2/~g/ml cytocha- 
lasin B) by 10 strokes of a homogenizer. The lysate was clarified by 
centrifugation at 200,000 x g for 90 min and applied to DEAE-Sephacel 
equilibrated with buffer B (the same as buffer A but 30 mM in KC1). 
Materials were eluted stepwise with buffer B containing 130 mM (lanes 
I and 2), 230 mM (lanes 3 and 4), and 530 mM (lanes 5 and 6) KC1. 
Each fraction was incubated with (lanes 2, 4, and 6) or without (lanes 
1, 3, and 5) 1.0 mM wild type NLS peptides of SV40 T-antigen in the 
presence of 10/.zM ATP containing 1 ¢tCi of [y-32p]ATP in an assay 
buffer (50 mM Tris-HCl (pH 7.5), 30 mM KC1, 5 mM MgCI_,) at 30°C 
for 10 rain. The reaction was terminated by the addition of Laemmli's 
sample buffer and boiling. After SDS-PAGE, bands were detected by 
autoradiography. The arrow indicates the position of p34. 
shown in Fig. 1, several phosphorylated proteins were detected. 
Of these phosphorylated proteins, a 32 kDa protein (p32) was 
specifically and strongly phosphorylated asa result of the injec- 
tion of wild type NLS peptides. For fractions obtained from 
oocytes injected with mutant ype N LS peptides, minimal phos- 
phorylation was observed. These results suggest he presence 
of a protein kinase which is activated in response to NLS 
peptides. 
In order to verify this, we examined whether kinase activity 
could also be detected in vitro. Initially, we fractionated the 
cytosol of Ehrlich ascites tumor cells using DEAE Sephacel 
column chromatography (as described in section 2) and incu- 
bated each fraction with or without peptides in the presence of 
10/.tM ATP containing 1 /.tCi [y-32p]ATP in the assay buffer. 
As shown in Fig. 2, several proteins were specifically 
phosphorylated by the addition of peptides of SV40 T-antigen 
wild type NLS. Among these proteins, a 34 kDa protein (p34), 
from the 530 mM KC1 fraction, was the major phosphorylated 
protein. As a result of this, the phosphorylation of p34 was used 
as an indicator of phosphorylation activity in subsequent exper- 
iments. In the next experiment, he 530 mM KC1 fraction was 
applied to a hydroxyl apatite column and the bound materials 
were eluted using a stepwise gradient of potassium phosphate 
as described in section 2. The most abundant kinase activity 
was obtained in the fraction which was eluted with 125 mM 
potassium phosphate. 
For further purification, the 125 mM fraction was subjected 
to gel filtration and in vitro phosphorylation was performed in 
each fraction. Phosphorylation of p34 was not detected in any 
of the fractions. Fractions which contained p34 were, however, 
obtained by visualization of the silver staining pattern of SDS- 
PAGE of each fraction. For confirmation, the p34-containing 
fractions were added to the other fractions and the in vitro 
phosphorylation reaction was performed in each mixture. As 
shown in Fig. 3, phosphorylation of p34 was detected in the 
mixtures and the kinase activity was separated into two peaks 
(peak I: about 360 kDa, peak II: about 150 kDa). These p34 
containing fractions were also used as a substrate in further 
experiments. At the present ime, it is not known whether p34 
is a mouse homologue of p32 which is phosphorylated in Xen- 
opus oocytes in an NLS-dependent manner as described above. 
Peak I was further separated by HPLC using a Mono-Q col- 
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Fig. 3. Sephacryl S-300 chromatography of NLS kinase. The 125 mM 
fraction of hydroxylapatite column chromatography was applied to 
Sephacryl S-300 (Pharmacia Biotechnology Inc.) equilibrated with 
buffer B. Fractions containing p34 (p34 fractions) were detected by 
silver staining of SDS-PAGE of each fraction. The phosphorylation f 
p34 was not detected in each fraction. Each fraction was mixed with 
p34 fractions and an in vitro phosphorylation was carried out as de- 
scribed in section 2. Two peaks for the kinase activity were obtained. 
The positions of kinase activity are indicated as I and II. Kinase activity 
was quantified by measuring the intensity of bands of p34 with a 
scanning densitometer (CS-930, Shimazu, Japan) and the maximum 
activity of peak 1 was represented as 1.0. 
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umn with a sodium chloride gradient. Fractions containing 
kinase activity were detected in three major bands (95, 70, and 
43 kDa) on SDS-PAGE by silver staining (Fig. 4A,B). These 
bands were not detected in fractions that were devoid of kinase 
activity. 
The high molecular masses of the two kinase-active peaks 
obtained by gel filtration, and the fact that three molecular 
species having kinase activity were eluted from Mono-Q col- 
umn, suggest hat these molecules may form a complex which 
has kinase activity. Based on the present data, however, we 
cannot say with certainty whether the formation of complexes 
is necessary for kinase activity, or not. Furthermore, we cannot 
exclude the possibility that some minor proteins, detected by 
silver staining, might be responsible for the kinase activity. 
The kinase fraction found in peak I was further characterized 
using the substrate fractions obtained by gel filtration. In order 
to confirm that the activation of the kinase is specific for NLS, 
we tested kinase activity by adding peptides of nucleoplasmin 
NLS and polyoma virus T-antigen NLS, which are competent 
for nuclear protein import, SV40 T-antigen transport incompe- 
tent mutant ype NLS, reverse type NLS and the C-terminal 
wild type (+) 
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Fig. 4. Mono-Q high performance liquid chromatography of NLS ki- 
nase. The kinase peak I, which contained the most abundant activity, 
obtained by Sephacryl S-300 chromatography, was applied to Mono-Q 
HR 5/5 column (Pharmacia Biotechnology Inc.) equilibrated with 
buffer D (20 mM Tris-HC1 (pH 7.2), 5 mM MgC12, 0.3 M KC1, 0.2 mM 
PMSF, 10/lg/ml eupeptin) and eluted with a linear gradient of 0.3 2 
M KCl in buffer D by high performance liquid chromatography 
(HPLC)(Pharmacia LKB Biotechnology Inc.). (A) An in vitro phos- 
phorylation assay was performed on samples (lanes 1 10) obtained 
after Mono-Q HPLC in the prescence of SV40 T-antigen wild type NLS 
peptides and p34 fractions obtained by Sephacryl S-300 gel filtration. 
Applied samples were mixed with p34 fractions and incubated with 
(lane 12) or without (lane 11) SV40 T-antigen wild type NLS peptides. 
The arrow indicates the position of p34. (B) The same samples as (A), 
lanes 1 11, were analysed by silver staining. Arrowheads indicate the 
position of major bands (95, 70, and 43 kDa) in the fractions which 
contain the kinase activity. 
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Fig. 5. NLS specificity of the kinase. Peptides of SV40 T-antigen wild 
type NLS (lane 1), mutant type NLS (lane 2), reverse type NLS (lane 
3), nucleoplasmin NLS (lane 4), polyoma virus T-antigen NLS (lane 5), 
and the C-terminal portion of lamin B (lane 6) at the final concentration 
of 1.0 mM were added to the reaction mixtures containing peak I of 
the kinase and p34 substrate fractions obtained by gel filtration. An in 
vitro phosphorylation was performed as described in section 2. The 
arrow indicates the position of p34. 
portion of lamin B, which contains no NLS region. As shown 
in Fig. 5, p34 was strongly phosphorylated by peptides of SV40 
T-antigen wild type NLS, nucleoplasmin NLS, and polyoma 
virus T-antigen NLS, but not by peptides of SV40 T-antigen 
mutant ype NLS, reverse type NLS, and the C-terminal por- 
tion of lamin B. These in vitro and in vivo results are fully 
consistent with the existence of a protein kinase which is acti- 
vated by NLS peptides and which we refer to as nuclear local- 
ization signal-activated kinase (NLS kinase). 
To further characterize the kinase, we examined whether 
common substrates of well-known kinases could be 
phosphorylated by the kinase. For these experiments, histone 
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H 1, protamine, myelin basic protein, casein, and phosvitin were 
used as substrates for in vitro phosphorylation. None of these 
substrates were phosphorylated by the NLS kinase (data not 
shown). On the contrary, histone HI, a karyohile, stimulated 
kinase activity. This observation supports the hypothesis that 
the kinase can be activated by NLS, although the NLS of 
histone H1 has not yet been determined. 
Very recently, Azuma et al. isolated a yeast protein kinase 
(Srplp kinase) which is activated by Srplp, a Saccharomyces 
cerevisiae homologue of importin 60, and showed the phospho- 
rylation of Srplp by Srplp kinase was enhanced in the presence 
of NLS peptides [34]. Srplp kinase phosphorylates a 36 kDa 
component of its protein kinase complex and its phosphoryla- 
tion is not affected by NLS peptides. In contrast, no phospho- 
rylation of any of the components of the NLS kinase fraction 
after Mono-Q column chromatography was observed even in 
the presence of NLS peptides. These data suggest that the NLS 
kinase is not a mouse homologue of Srplp kinase. However, 
we have not yet examined whether PTAC 58 is phosphorylated 
by the NLS kinase. 
Stochaj and Silver reported that the 70 kDa yeast NLS recep- 
tor lost NLS binding ability after treatment with phosphatase 
[35]. They showed that protein phosphorylation, which might 
produce ither a direct modification of the NLS binding site or 
a change in protein conformation, was necessary for NLS- 
binding. Although ATP was not essential for the first step of 
the transport, he existence of the NLS kinase and its substrates 
in the cytosolic extracts uggest that this kinase might regulate 
the efficiency of nuclear pore targeting. 
Mishra and Parnaik showed that treatment of semi-intact 
cells with alkaline phosphatase abolished nuclear protein im- 
port and that the insoluble structural proteins of 6~62 kDa of 
NPCs were predominantly phosphorylated byboth protein ki- 
nase A and protein kinase C and that, after this phosphoryla- 
tion, nuclear transport was restored [36]. Similarly, the NLS 
kinase might have an potential role in changing the conforma- 
tion of NPCs by protein phosphorylation thus permitting kar- 
yophiles to bind to or translocate hrough the pores. In order 
to determine if NPCs can be phosphorylated by the NLS ki- 
nase, a crude fraction of NPCs, prepared from rat liver nuclei, 
was used as substrates in an in vitro assay. This crude fraction, 
however, was not phosphorylated under the conditions at 
which p34 was phosphorylated ( ata not shown). These find- 
ings, however, do not completely exclude the possibility that 
components of NPCs could serve as substrates for the NLS 
kinase, since this reaction was not studied by using more puri- 
fied NPCs or over a wide range of assay conditions. 
In terms of functionality, the NLS kinase may play an impor- 
tant role in the regulation of diverse cellular functions uch as 
cell cycle control or signal transduction without a direct rela- 
tionship to nuclear transport. Isolation of the genes for the NLS 
kinase and its substrate would, of course, lead to a more com- 
plete understanding of the exact cellular function and role of 
the kinase. 
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